Source: NEJM Once-Weekly Semaglutide Study Clinical vs
Building a market position Langers is working on making the No Worries GLP-1 support beverage available through both online and retail locations
Om recommends oral antibiotics, hormonal therapies like birth control pills, and oral spironolactone as effective alternatives for moderate to severe acne
The FLOW trial is a major phase 3b study that found weekly 1.0 mg injections of semaglutide significantly protect kidney function and reduce cardiovascular deaths in patients with type 2 diabetes and chronic kidney disease (CKD)
Some uses are for increased energy, weight loss, stress relief, mental and emotional stability, and supplementation of diets deficient in B Vitamins, and treatment of vitamin B12 deficiencies
Information about The Lamkin Clinic and peptide therapy approaches is based on current clinical practices in functional medicine